Beyond Initial Response: Long-term Monitoring and Management in MASH
Overview
Challenge yourself with this CME/CE-accredited Interactive Case Challenge. Explore evidence-based strategies for the long-term management of MASH, with a focus on sustained response and comorbidity control. Learn how to incorporate incretin-based therapies and apply updated guidelines and patient-specific factors to optimize treatment outcomes over time.
Disclosures
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Primary Author
Kathleen Corey, MD, MPH, MMSc, has no relevant financial relationships to disclose.
The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES, as noted below:
Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES: consultant/advisor/speaker: Abbott, Novo Nordisk, Xeris.
Learning objectives
Upon completion of this activity, participants should be able to:
- Identify the role of incretin-based therapies in the management of MASH and cardiometabolic comorbidities.
- Integrate the latest guidelines, evidence, and patient-specific factors into comprehensive treatment plans for patients with MASH.
Key dates
- Released date:
- Jul 13, 2025
- Expiration date:
- Jul 14, 2026
Sponsor
Provided by Clinical Care Options, LLC in partnership with AGA
Supporter acknowldegement
Supported by an educational grant from Novo Nordisk.Agenda
All times are Eastern.
Session Heading 1: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Session Heading 2: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Course Faculty and Disclosures
Faculty
Kathleen Corey, MD, MPH, MMSc
Director, MASLD Program
Massachusetts General Hospital Associate Professor Harvard Medical School Boston, Massachusetts